The global disposable syringes market size is predicted to hit around US$ 11.02 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
In 2022, the disposable syringes market study provides crucial information on market share, market size, growth rate analysis Y-O-Y, production, consumption, and sales analysis for the forecast period 2021 to 2030. The report contains 150+ pages with detailed analysis.
Disposable syringes are very common within the healthcare industry. They are relatively inexpensive and easy to mass-manufacture allowing for anadvanced level of availability. Usually speaking, syringes are devices used to insert or draw formulations from a bigger body. Usually functioned via a piston-pump arrangement, they are the chief method by which a clinician or nurse administers medication to the patients. Previously, syringes were cleaned and reprocessed. However, in the modern periods the use-and-throw syringe has increased in popularity over the outdated reusable type of syringe. The prime difference being that a use-and-throw syringe is envisioned for one-time usage and is then thrown away, typically into aninfection unit. While very simple in idea, syringes have numerous variants and fragments which are transposable dependent on the proposed use of the syringe. Usually, these are features which might vary reliant on on the syringe being employed.
Factors such as increasing number of patients at risk of developing stroke, increasing patient awareness, increased health care expenditure, large pool of geriatric population, growing usage of injectable drugs, higher bioavailability of injectable drugs, growing instances of needlestick injuries, increasing cases of chronic disorders such as diabetes and chronic, and increased preference of intravenous route of drug administration are driving the growth of disposable syringes market. Moreover, Additional features that are expected to fuel this businessare integration of latest technologies for disposable syringes and growing investment by major players.
As per WHO (World Health Organization), the number of cancer cases globally reached 19.3 million in the year 2020. With increasing number of cancer cases, the demand for disposable syringes is also growing due to its predominant use in medical care for several cancers like ovarian cancer, breast cancer, non-small cell lung cancer, lung cancer, AIDS related Kaposi’s sarcoma, cervical cancer, prostate cancer, pancreatic cancer, esophageal cancer, stomach cancer, and testicular cancer among others. It is expected that between the years 2018 and 2040, the extent of patients needing first-line chemotherapy worldwide each year will surge 53% that is to 15 million from 9.8 million. The growth in chemotherapy demand will principally be an outcome of population rise and projected variations in the dispersal of cancer types by nation which is expected to boost the requirement for the disposable syringes in the near future.
Scope of the Disposable Syringes Market
|USD 11.02 Billion by 2030
|CAGR of 5.6% From 2022 to 2030
|2017 to 2021
|2022 to 2030
|North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The disposable syringes report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.
The report includes information for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. In 2020, the North America dictated the globalindustry with a market stake of greater than 41%. The U.S. indicated the highest slice in North America principally due to increasing cases of cancer and early adoption of latest healthcare equipment’s. Moreover, availability of latest healthcare infrastructure also supported the high market portion of North America.
Europe was the subsequent significant market chiefly due to presence of skilled physicians. Presence of major companies in the European region is also expected to lift the demand for disposable syringes in the anticipated time-span. The Asia Pacific region is projected to grow at the highest CAGR of around6.9% in the estimate period due to increasing healthcare expenditure. Latin America and Middle East and African region will display noticeable growth.
The disposable syringes market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.
Some of the prominent players in the disposable syringes market include:
- Fresenius Kabi AG
- Flextronics International Vita Needle Company
- Braun Medical, Inc.
- Baxter International, Inc.
- Terumo Corporation
- Novo Nordisk
- Henke-Sass, Wolf
- Retractable Technologies, Inc.
- UltiMed, Inc.
- Becton, Dickinson and Company
- Conventional Syringes
- Safety Syringes
- Retractable Safety Syringes
- Non-retractable Safety Syringes
- Immunization Injections
- Therapeutic Injections
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Find More Press Releases at https://www.globenewswire.com/en/search/organization/Precedence%2520Researchv
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Call: +1 9197 992 333